Abstracts tagged "Infliximab and sarcoidosis"

Abstract Number: 1245 • ACR/ARHP Annual Meeting 2014

Long Term Outcome of Infliximab in Severe and Refractory Systemic Sarcoidosis: Report of 16 Cases

Catherine Chapelon¹, David Saadoun¹, Lucie Biard², Matthieu Resche-Rigon³, Baptiste Hervier⁴, Nathalie Costedoat-Chalumeau⁵, Aurélie Drier⁶, Jean-Marc Léger⁷ and Patrice Cacoub⁸, ¹DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, Paris, France, ²Hôpital St Louis, Biostatistics, Paris, France, ³Biostatistics, Hopital Saint-Louis, Paris, France, ⁴Department: inflammation, immunopathology and biotherapy (DHU i2B), Assistance Publique - Hôpitaux de Paris, Pitié-Salpêtrière University Hospital, PARIS, France, ⁵Internal Medicine, Assistance Publique-Hôpitaux de Paris, Hopital Pitié-Salpétrière, Paris, France, ⁶Hôpital Pitié-Salpêtrière, Neuroradiology, Paris, France, ⁷Neurology, Hôpital Pitié-Salpêtrière, Neurology, Paris, France, ⁸Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France